SBC Medical Group Holdings Inc., a Japanese aesthetic medical clinic operator, has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking its official entry into the American market. The partnership enables SBC to leverage OrangeTwist's 24 locations across six states and its advanced management system integrating procurement, clinical workflows, and real-time KPI tracking. This move comes as the medical aesthetics industry is forecast to grow from $34 billion today to $48 billion by 2030, driven by demand for non-surgical treatments with minimal risk and downtime.
The collaboration addresses a critical issue in the U.S. medspa market known as "white space," where cities have high demand for services but few competitors. By combining resources, the companies plan to enter these underserved markets, securing first-mover advantages. SBC will provide funding and operational expertise to help OrangeTwist enhance its offerings and accelerate new location openings. Stephen Rodgers, global head of planning and strategy at SBC Medical, emphasized the company's strategy of finding local partnerships rather than replicating its Japanese model, seeking partners that align with its mission and can scale effectively.
Beyond joint clinic operations, OrangeTwist and SBC plan to co-develop branded products and sell existing products in each other's spas. This expansion is part of SBC's broader strategy to capitalize on the global longevity industry, which is shifting from merely increasing lifespan to boosting "healthspan" through personalized, preventative solutions. According to Gabelli Research, the global anti-aging market, valued at approximately $85 billion in 2025, is expected to surpass $120 billion by 2030, with North America accounting for 30% of the market. SBC believes its infrastructure positions it to offer AI-powered diagnostics, GLP-1 weight-loss drugs, and regenerative therapies.
Simultaneously, SBC is expanding in Japan and Southeast Asia, applying its proven business model to standardize services and ensure consistent quality and pricing. The company's global strategy rests on partnering with high-performing regional operators, deploying expertise to drive efficiencies, and securing first-mover advantages. This approach is being implemented in markets like Thailand and Singapore, where non-invasive treatments are in high demand due to preferences for natural-looking results with minimal recovery times.
The investment highlights SBC's transformation from a local operator into a global network, creating a partnership model that can be replicated across countries. By sharing its successful approach with local providers, SBC aims to establish a trusted brand for aesthetic beauty services worldwide. The aging population, with 4.1 million people turning 65 annually in the U.S. alone, is driving demand for these services, making this expansion timely and strategically significant for both companies and the broader industry.
